Key Stats for Axon Stock
- Current Price: $571.01
- Target Price (Mid): ~$1,800
- Street Target: ~$670
- Potential Total Return: ~216%
- Annualized IRR: ~30% / year
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
Axon Enterprise (AXON) gave investors two answers to the same earnings report. The company posted second-quarter results after the close on August 5, and shares actually finished that regular session slightly higher. The reaction came the next day: the stock fell 14.28% on August 6, then rebounded 9.29% to close at $571.01 on August 7. Nothing in the report changed between those sessions. What changed was which part of it investors decided to weigh.
The quarter was strong on its face. Revenue rose 35% year over year to $904.4 million, beating the Street’s $876 million estimate and marking the tenth consecutive quarter of growth above 30%. Management raised full-year revenue growth guidance to 32% to 34%, up 200 basis points. So the selloff was not about the top line. It was about a one-cent adjusted earnings miss, a premium valuation, and a warning in the margin commentary.
Why a record quarter sold off, then bounced
Adjusted earnings came in at $1.88 per share against a $1.84 consensus, though it fell a penny short of the $1.89 figure some data providers carried. Adjusted EBITDA reached $242 million at a 26.8% margin. Annual recurring revenue grew 39% to $1.6 billion, and net revenue retention climbed to 126%, up from the 119% level the company sat at for years. Future contracted bookings grew more than 40% to $15.1 billion.
The selloff came from the margin commentary, not the growth. CFO Brittany Bagley held the full-year adjusted EBITDA margin target at roughly 25.5% despite the beat, because a Q2 tariff refund that lifted gross margin will not repeat, and memory component costs are rising into the second half. As she put it: “We expect Q3 adjusted EBITDA margin to reflect the impact of those memory costs with no benefit from tariff refunds before we scale margins back in Q4.” For a stock trading above 60 times forward earnings after a sharp run into the print, a telegraphed margin step-down was enough to trigger selling.
The next session bought it back because the guidance raise does not fit a soft outlook. Management does not lift a full-year range by 200 basis points while signaling trouble. President Josh Isner said gross bookings rose 20% on top of nearly 50% growth a year earlier, and grew more than 30% on a five-year normalized basis that strips out contract-duration noise. International bookings came in at roughly three times the prior year, with three of the top five AI Era Plan deals in the quarter coming from international customers. That breadth reads as durable demand, not a pulled-forward quarter.
See historical and forward estimates for Axon stock (It’s free!) >>>
The software mix is doing the heavy lifting
Software & Services revenue grew 36% to $398 million, and more than a third of that now comes from offerings beyond the core evidence platform. That newer cohort, spanning real-time operations, records, counter-drone software, and Axon 911, grew roughly 70% year over year. The AI Era Plan grew almost 700%.
Counter-drone gave the rebound something concrete to price. Dedrone surpassed $100 million in quarterly revenue for the first time and drove Platform Solutions revenue up 123% to $150 million. Axon was also named one of a handful of participants selected from 55 to 60 applicants for a $1.5 billion Department of Homeland Security counter-UAS program. That is a selection to compete, not a signed award, and management said the captured share is still unclear. It is validation in a market Axon entered less than two years ago.
CEO Patrick Smith framed the wider bet in one line: “There is no company better positioned to benefit from the intelligence explosion than Axon.” His argument is that AI models perceive the world through text, while Axon perceives it through the largest connected sensor network in public safety and can act on what it sees. Whether that earns a 60-times multiple is the argument the two trading sessions were really having.
See how Axon performs against its peers in TIKR (It’s free!) >>>
What the multiple already assumes
At a next-twelve-month EV/EBITDA multiple near 43 times and roughly 63 times forward earnings, it sits at a steep premium to the primes. Lockheed Martin trades near 13 times forward EBITDA, General Dynamics near 16 times, and even fast-growing Howmet Aerospace near 33 times. The closest comparison is a high-multiple software compounder, not a defense name, and that is the lens the model uses. The premium holds only if software and counter-drone keep compounding at the rates just reported.
TIKR Advanced Model Analysis
- Current Price: $571.01
- Target Price (Mid): ~$1,800
- Potential Total Return: ~216%
- Annualized IRR: ~30% / year
See analysts’ growth forecasts and price targets for Axon stock (It’s free!) >>>
TIKR’s mid-case scenario points to a target of around $1,800 by the end of 2030, implying roughly 216% total upside from the current price, or about 30% annualized over the next 4.4 years. That sits far above the Street’s mean target of around $670, and the gap is mostly time horizon: the model runs to 2030 while analyst targets look 12 months out.
The target rests on two revenue drivers: continued 20%-plus growth in the core software and sensor ecosystem, and the scaling of newer lines like counter-drone and Axon 911 that grew triple digits this quarter. The margin driver is net income margin holding near 19% as the software mix rises. The primary risk is what spooked the market on August 6: if memory costs and new-business mix compress margins for longer than a couple of quarters, the earnings base that justifies the multiple arrives later than modeled. Upside is a business compounding revenue in the low-20s while margins stay firm, which today’s price fails to credit. Downside is a durable growth story bolted to a valuation that leaves no room for a stumble.
Conclusion
The next real test is Q3, which Axon typically reports in early November. Management has already told investors what “bad” looks like: an adjusted EBITDA margin that steps down on memory costs and stays down. “Good” is a margin that dips in Q3 as guided, then scales back toward the 25.5% full-year target in Q4, confirming the squeeze was a timing issue and not a trend. Watch that single line. If margins rebound as promised while ARR holds near 39% growth, the August 7 buyers were right. If they do not, the August 6 sellers were early, not wrong.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in Axon?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Axon, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Axon alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
